Authors: Mohrschladt, MF de Maat, MPM Westendorp, RGJ Smelt, AHM

Citation: Mf. Mohrschladt et al., C-reactive protein in patients with familial hypercholesterolemia: no effect of simvastatin therapy, ATHEROSCLER, 157(2), 2001, pp. 491-494

Authors: Mohrschladt, MF Smelt, AHM Westendorp, RGJ

Citation: Mf. Mohrschladt et al., Endotoxin-lipoprotein hypothesis, LANCET, 356(9247), 2000, pp. 2097-2097

Authors: Mohrschladt, MF Weverling-Rijnsburger, AWE de Man, FHAF Stoeken, DJ Sturk, A Smelt, AHM Westendorp, RGJ

Citation: Mf. Mohrschladt et al., Hyperlipoproteinemia affects cytokine production in whole blood samples exvivo. The influence of lipid-lowering therapy, ATHEROSCLER, 148(2), 2000, pp. 413-419

Authors: Mohrschladt, MF Bijlsma, EK Sluijter, S De Coo, RFM Hoovers, JMN Leschot, NJ

Citation: Mf. Mohrschladt et al., A patient with a de novo t(6;9) and an interstitial duplication of (9)(q21.2q22.1), CLIN DYSMOR, 8(3), 1999, pp. 211-214

Authors: Kluft, C de Maat, MPM Leuven, JAG van Loon, BJP Mohrschladt, MF

Citation: C. Kluft et al., Statins and C-reactive protein, LANCET, 353(9160), 1999, pp. 1274-1274